Search
Establishment of Nation-Wide Class Rejected in Securities Case
Establishment of Nation-Wide Class Rejected in Securities Case

In Jackie 888, Inc. v. Tokai Pharmaceuticals, Inc., Jackie 888 sued Tokai on behalf of itself and a putative class of individuals who had purchased Tokai stock, alleging Tokai made misleading statements in an IPO registration statement and prospectus. Jackie 888 moved for class certification.

The class-certification motion, Judge Sanders wrote, raised this question: “[Can] a Massachusetts state court … consistent with Due Process, certify a nationwide class and thus exercise personal jurisdiction over out-of-state plaintiffs where Massachusetts Rule 23 does not contain a provision allowing these absent class members to ‘opt out’”?

The answer, Judge Sanders ruled, is no.

Citing Moelis v. Berkshire Life Ins. Co., 451 Mass. 483 (2008), Judge Sanders pointed out that where a plaintiff cannot procedurally opt out of a class, a Massachusetts court can assert personal jurisdiction over absent class plaintiffs only if they had “minimum contacts” with the Commonwealth. Turning to the facts, Judge Sanders found that the absent class plaintiffs’ only contact with Massachusetts—the purchase of stock (through agents in other states) issued by a Delaware corporation headquartered in Massachusetts—did not meet the minimum-contacts test.

Judge Sanders rejected Jackie 888’s argument that absent class members’ stock purchases themselves constituted minimum contacts with the Commonwealth. “This argument,” Judge Sanders wrote, “misses the point in that it focuses on the defendants’ rather than the plaintiffs’ contacts with the forum state.”

We previously blogged about a similar decision from Judge Kaplan, who stayed a securities litigation filed in the BLS in favor of a parallel case filed in federal court. We blogged about that case—Lowinger v. Solid Biosciences Inc.—here.

The Business Litigation Session of the Massachusetts Superior Court

Docket Number: 2018-1591-BLS 2

Case Name: Jackie 888, Inc., individually and behalf of other similarly situated v. Tokai Pharmaceuticals, Inc., et al.

Date of Decision: November 25, 2019

Judge: Janet L. Sanders

Blog Editor

Recent Posts

Back to Page

Nutter McClennen & Fish LLP Cookie Preference Center

Your Privacy

When you visit our website, we use cookies on your browser to collect information. The information collected might relate to you, your preferences, or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. For more information about how we use Cookies, please see our Privacy Policy.

Strictly Necessary Cookies

Always Active

Necessary cookies enable core functionality such as security, network management, and accessibility. These cookies may only be disabled by changing your browser settings, but this may affect how the website functions.

Functional Cookies

Always Active

Some functions of the site require remembering user choices, for example your cookie preference, or keyword search highlighting. These do not store any personal information.

Form Submissions

Always Active

When submitting your data, for example on a contact form or event registration, a cookie might be used to monitor the state of your submission across pages.

Performance Cookies

Performance cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.

Powered by Firmseek